Showing 1 to 8 of 8 results
Low-Dose Aspirin May Reduce Cancer Risk in Older Adults
A five-year Australian study of almost 10,000 adults aged 71-77 found that daily low-dose aspirin was associated with a 15% lower cancer risk, particularly among older participants with specific characteristics.
Low-Dose Aspirin May Reduce Cancer Risk in Older Adults
A five-year Australian study of almost 10,000 adults aged 71-77 found that daily low-dose aspirin was associated with a 15% lower cancer risk, particularly among older participants with specific characteristics.
Progress
28% Bias Score
Aspirin: A Potential Life-Saver During Heart Attacks
Melbourne emergency doctor Dr. Katie highlights the life-saving potential of chewing an aspirin at the first sign of a heart attack, emphasizing immediate emergency service calls and aspirin's role in slowing clot formation.
Aspirin: A Potential Life-Saver During Heart Attacks
Melbourne emergency doctor Dr. Katie highlights the life-saving potential of chewing an aspirin at the first sign of a heart attack, emphasizing immediate emergency service calls and aspirin's role in slowing clot formation.
Progress
48% Bias Score
Common Pain Relievers Show Promise in Cancer Prevention and Treatment
Studies show common pain relievers like aspirin, ibuprofen, and diclofenac may prevent cancer recurrence by inhibiting the enzyme cyclooxygenase-1, reactivating T-cells to destroy micrometastases, with effectiveness varying across cancer types and patient genetic factors, although potential side eff...
Common Pain Relievers Show Promise in Cancer Prevention and Treatment
Studies show common pain relievers like aspirin, ibuprofen, and diclofenac may prevent cancer recurrence by inhibiting the enzyme cyclooxygenase-1, reactivating T-cells to destroy micrometastases, with effectiveness varying across cancer types and patient genetic factors, although potential side eff...
Progress
40% Bias Score
Aspirin Found to Inhibit Cancer Spread by Boosting Immune Response
Research published in Nature reveals how aspirin inhibits thromboxane A2 (TXA2), a clotting factor suppressing T cells, thus potentially preventing cancer spread; clinical trials are underway, but experts advise consulting a doctor before using aspirin for cancer treatment.
Aspirin Found to Inhibit Cancer Spread by Boosting Immune Response
Research published in Nature reveals how aspirin inhibits thromboxane A2 (TXA2), a clotting factor suppressing T cells, thus potentially preventing cancer spread; clinical trials are underway, but experts advise consulting a doctor before using aspirin for cancer treatment.
Progress
40% Bias Score
Aspirin Reduces Colorectal Cancer Recurrence Risk
A Swedish study found that colorectal cancer patients with specific genetic mutations taking daily low-dose aspirin after surgery were 55% less likely to experience cancer recurrence within three years compared to a placebo group.
Aspirin Reduces Colorectal Cancer Recurrence Risk
A Swedish study found that colorectal cancer patients with specific genetic mutations taking daily low-dose aspirin after surgery were 55% less likely to experience cancer recurrence within three years compared to a placebo group.
Progress
36% Bias Score
Clopidogrel Superior to Aspirin in Preventing Cardiovascular Events
A new study published in the Lancet reveals that clopidogrel, a blood thinner, is more effective than aspirin in preventing major cardiovascular events in patients with coronary artery disease (CAD), without increasing the risk of bleeding.
Clopidogrel Superior to Aspirin in Preventing Cardiovascular Events
A new study published in the Lancet reveals that clopidogrel, a blood thinner, is more effective than aspirin in preventing major cardiovascular events in patients with coronary artery disease (CAD), without increasing the risk of bleeding.
Progress
40% Bias Score
Aspirin Shows Promise in Cancer Fight: Animal Study
Aspirin, a common pain reliever, shows promise in fighting cancer by enhancing the immune system's ability to destroy spreading cancer cells, according to a University of Cambridge animal study, though human trials are needed to confirm its efficacy and safety.
Aspirin Shows Promise in Cancer Fight: Animal Study
Aspirin, a common pain reliever, shows promise in fighting cancer by enhancing the immune system's ability to destroy spreading cancer cells, according to a University of Cambridge animal study, though human trials are needed to confirm its efficacy and safety.
Progress
40% Bias Score
Boots Recalls 110,000 Paracetamol Packs Due to Mislabeling
Boots is recalling 110,000 packs of 500mg paracetamol tablets due to mislabeling as 300mg aspirin (batch 241005, expiry 12/2029); customers can get a full refund.
Boots Recalls 110,000 Paracetamol Packs Due to Mislabeling
Boots is recalling 110,000 packs of 500mg paracetamol tablets due to mislabeling as 300mg aspirin (batch 241005, expiry 12/2029); customers can get a full refund.
Progress
16% Bias Score
Showing 1 to 8 of 8 results